Matches in SemOpenAlex for { <https://semopenalex.org/work/W2742885672> ?p ?o ?g. }
- W2742885672 endingPage "29" @default.
- W2742885672 startingPage "20" @default.
- W2742885672 abstract "Human interferon gamma (hIFNγ) affects tumour cells and modulates immune responses, showing promise as an anti-cancer biotherapeutic. This study investigated the effect of glycosylation and expression system of recombinant hIFNγ in ovarian carcinoma cell lines, PEO1 and SKOV3. The efficacy of E. coli- and mammalian-expressed hIFNγ (hIFNγ-CHO and HEK293, glycosylated/de-glycosylated) on cytostasis, cell death (MTT, and Guava-ViaCount® flow-cytometry) and apoptotic signalling (Western blot of Cdk2, histone H3, procaspase-3, FADD, cleaved PARP, and caspase-3) was examined. Hydrophilic Interaction Liquid Chromatography determined the structure of N-linked glycans present in HEK293-expressed hIFNγ (hIFNγ-HEK). PEO1 was more sensitive to hIFNγ than SKOV3, but responses were dose-dependent and expression platform/glycosylation status-independent, whereas SKOV3 responded to mammalian-expressed hIFNγ in a dose-independent manner, only. Complex-type oligosaccharides dominated the N-glycosylation pattern of hIFNγ-HEK with some terminal sialylation and core fucosylation. Cleaved PARP and cleaved caspase-3 were not detected in either cell line, but FADD was expressed in SKOV3 with levels increased following treatment. In conclusion, hIFNγ did not induce apoptosis in either cell line. Mammalian- expressed hIFNγ increased cell death in the drug-resistant SKOV3. The presence of FADD in SKOV3, which may inhibit apoptosis through activation of NF-κB, could serve as a novel therapeutic target." @default.
- W2742885672 created "2017-08-17" @default.
- W2742885672 creator A5010756863 @default.
- W2742885672 creator A5041409120 @default.
- W2742885672 creator A5054797821 @default.
- W2742885672 creator A5061216746 @default.
- W2742885672 creator A5072978910 @default.
- W2742885672 creator A5075412846 @default.
- W2742885672 creator A5084228392 @default.
- W2742885672 date "2017-10-01" @default.
- W2742885672 modified "2023-10-03" @default.
- W2742885672 title "Improved therapeutic efficacy of mammalian expressed-recombinant interferon gamma against ovarian cancer cells" @default.
- W2742885672 cites W1567072634 @default.
- W2742885672 cites W1590342103 @default.
- W2742885672 cites W1736358599 @default.
- W2742885672 cites W1822555195 @default.
- W2742885672 cites W1970898345 @default.
- W2742885672 cites W1978374942 @default.
- W2742885672 cites W1989474275 @default.
- W2742885672 cites W1997984454 @default.
- W2742885672 cites W2012422873 @default.
- W2742885672 cites W2014664217 @default.
- W2742885672 cites W2023122823 @default.
- W2742885672 cites W2027894892 @default.
- W2742885672 cites W2030646603 @default.
- W2742885672 cites W2031572048 @default.
- W2742885672 cites W2035057964 @default.
- W2742885672 cites W2035591709 @default.
- W2742885672 cites W2035835337 @default.
- W2742885672 cites W2035842919 @default.
- W2742885672 cites W2036930922 @default.
- W2742885672 cites W2042811130 @default.
- W2742885672 cites W2046655428 @default.
- W2742885672 cites W2052313621 @default.
- W2742885672 cites W2056039042 @default.
- W2742885672 cites W2056635301 @default.
- W2742885672 cites W2073290833 @default.
- W2742885672 cites W2073778217 @default.
- W2742885672 cites W2088434373 @default.
- W2742885672 cites W2091881371 @default.
- W2742885672 cites W2092578913 @default.
- W2742885672 cites W2097915503 @default.
- W2742885672 cites W2118982362 @default.
- W2742885672 cites W2148253377 @default.
- W2742885672 cites W2167430243 @default.
- W2742885672 cites W2205815637 @default.
- W2742885672 cites W2312543132 @default.
- W2742885672 cites W2320336142 @default.
- W2742885672 cites W2540522984 @default.
- W2742885672 cites W2547805125 @default.
- W2742885672 cites W4321258480 @default.
- W2742885672 doi "https://doi.org/10.1016/j.yexcr.2017.08.014" @default.
- W2742885672 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28803068" @default.
- W2742885672 hasPublicationYear "2017" @default.
- W2742885672 type Work @default.
- W2742885672 sameAs 2742885672 @default.
- W2742885672 citedByCount "16" @default.
- W2742885672 countsByYear W27428856722018 @default.
- W2742885672 countsByYear W27428856722019 @default.
- W2742885672 countsByYear W27428856722020 @default.
- W2742885672 countsByYear W27428856722021 @default.
- W2742885672 countsByYear W27428856722022 @default.
- W2742885672 countsByYear W27428856722023 @default.
- W2742885672 crossrefType "journal-article" @default.
- W2742885672 hasAuthorship W2742885672A5010756863 @default.
- W2742885672 hasAuthorship W2742885672A5041409120 @default.
- W2742885672 hasAuthorship W2742885672A5054797821 @default.
- W2742885672 hasAuthorship W2742885672A5061216746 @default.
- W2742885672 hasAuthorship W2742885672A5072978910 @default.
- W2742885672 hasAuthorship W2742885672A5075412846 @default.
- W2742885672 hasAuthorship W2742885672A5084228392 @default.
- W2742885672 hasConcept C153911025 @default.
- W2742885672 hasConcept C174510640 @default.
- W2742885672 hasConcept C190283241 @default.
- W2742885672 hasConcept C2776055636 @default.
- W2742885672 hasConcept C2777313579 @default.
- W2742885672 hasConcept C31573885 @default.
- W2742885672 hasConcept C502942594 @default.
- W2742885672 hasConcept C54355233 @default.
- W2742885672 hasConcept C55493867 @default.
- W2742885672 hasConcept C81885089 @default.
- W2742885672 hasConcept C86803240 @default.
- W2742885672 hasConcept C98424977 @default.
- W2742885672 hasConceptScore W2742885672C153911025 @default.
- W2742885672 hasConceptScore W2742885672C174510640 @default.
- W2742885672 hasConceptScore W2742885672C190283241 @default.
- W2742885672 hasConceptScore W2742885672C2776055636 @default.
- W2742885672 hasConceptScore W2742885672C2777313579 @default.
- W2742885672 hasConceptScore W2742885672C31573885 @default.
- W2742885672 hasConceptScore W2742885672C502942594 @default.
- W2742885672 hasConceptScore W2742885672C54355233 @default.
- W2742885672 hasConceptScore W2742885672C55493867 @default.
- W2742885672 hasConceptScore W2742885672C81885089 @default.
- W2742885672 hasConceptScore W2742885672C86803240 @default.
- W2742885672 hasConceptScore W2742885672C98424977 @default.
- W2742885672 hasFunder F4320320982 @default.
- W2742885672 hasIssue "1" @default.
- W2742885672 hasLocation W27428856721 @default.